REGENXBIO
Company Overview
Overall Headcount Trend
Overall Headcount Trend
Company growth over the last 12 months
Salaries
Job Posting Salary Data
From 1 marketing roles posted in the last 12 months
Community Salary Data
Help build salary transparency at REGENXBIO. Share your compensation anonymously.
Reviews
Jobs
About REGENXBIO
REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. Since its founding in 2009, REGENXBIO has pioneered the development of AAV Therapeutics, an innovative class of gene therapy medicines. REGENXBIO is advancing a pipeline of AAV Therapeutics for retinal and rare diseases, including ABBV-RGX-314 for the treatment of wet AMD and diabetic retinopathy, being developed in collaboration with AbbVie, RGX-202 for the treatment of Duchenne and RGX-121 for the treatment of MPS II. Thousands of patients have been treated with REGENXBIO’s AAV Therapeutic platform, including Novartis’ ZOLGENSMA for children with spinal muscular atrophy. Designed to be one-time treatments, AAV Therapeutics have the potential to change the way healthcare is delivered for millions of people.
Company Information
- Company Type
- In-House Team
- Company Size
- Founded
- 2008
- Headquarters
- Rockville
Why Work at REGENXBIO?
Discover what makes REGENXBIO a great place to build your marketing career. View salary data, benefits, and employee insights on the other tabs.
